Cascade Infectious Diseases And Infusion LLC is categorized under Doctors in Salem, OR and active since 2009.
Cascade Infectious Diseases And Infusion LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact John C Girod at the company’s single location by writing to 2720 Coml St Se # 201, Salem, Oregon OR 97302 or by phoning (503) 540-9999. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cascade Infectious Diseases And Infusion LLC |
| Contact Person: | John C Girod |
| Address: | 2720 Coml St Se # 201, Salem, Oregon 97302 |
| Phone Number: | (503) 540-9999 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Cascade Infectious Diseases And Infusion LLC was started in 2009 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact John C Girod for inquiries that concern Cascade Infectious Diseases And Infusion LLC by calling the company number (503) 540-9999, as your correspondence is most welcome. Additionally, the physical location of the single location of Cascade Infectious Diseases And Infusion LLC can be found at the coordinates 44.9039,-123.04516 as well as the street address 2720 Coml St Se # 201 in Salem, Oregon 97302.
For its online presence, you may visit Cascade Infectious Diseases And Infusion LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.